相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells
David Alvarez-Guardia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2011)
Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis
Jeffrey M. Peters et al.
CANCER AND METASTASIS REVIEWS (2011)
Activation of Peroxisome Proliferator-Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleuldn-6 Stimulated Adipocytes
Lucia Serrano-Marco et al.
DIABETES (2011)
Role of Lipid Peroxidation and PPAR-δ in Amplifying Glucose-Stimulated Insulin Secretion
Guy Cohen et al.
DIABETES (2011)
Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
Carlo Piccinni et al.
DIABETES CARE (2011)
The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
Emma Barroso et al.
ENDOCRINOLOGY (2011)
Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies
Dick C. Chan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Mehdi Daoudi et al.
GASTROENTEROLOGY (2011)
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
Esther M. M. Ooi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The obese healthy paradox: is inflammation the answer?
Nuria Barbarroja et al.
BIOCHEMICAL JOURNAL (2010)
Mitochondrial dysfunction and lipotoxicity
Patrick Schrauwen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Obesity, Inflammation, and Cardiovascular Risk
P. Mathieu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus
Devjit Tripathy et al.
CURRENT DIABETES REPORTS (2010)
Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature
L. Nalysnyk et al.
DIABETES OBESITY & METABOLISM (2010)
Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells
Teresa Coll et al.
ENDOCRINOLOGY (2010)
Improved insulin sensitivity and islet function after PPARδ activation in diabetic db/db mice
Maria Sorhede Winzell et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Leukotriene B4 Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-α Agonist
Venkata R. Narala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Saturated Fatty Acid-Induced Insulin Resistance Is Associated With Mitochondrial Dysfunction in Skeletal Muscle Cells
Sandro M. Hirabara et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer
Jeffrey M. Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Manu V. Chakravarthy et al.
CELL (2009)
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Bei B. Zhang et al.
CELL METABOLISM (2009)
Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet-Induced Insulin Resistance
Clinton R. Bruce et al.
DIABETES (2009)
Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies
S. Del Prato
DIABETIC MEDICINE (2009)
Emerging Concepts in The Pathophysiology of Type 2 Diabetes Mellitus
Prasanth N. Surampudi et al.
MOUNT SINAI JOURNAL OF MEDICINE (2009)
Peroxisome proliferator-activated receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged mice
C. Giordano et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
Metabolic syndrome pandemic
Scott M. Grundy
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
Elizabeth E. Girroir et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity
Kihwa Kang et al.
CELL METABOLISM (2008)
Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
Jeffrey M. Peters et al.
CLINICAL SCIENCE (2008)
Activation of peroxisome proliferator-activated receptor β/δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-κB activity via extracellular signal-related kinase 1/2
Ricardo Rodriguez-Calvo et al.
DIABETES (2008)
The Residual Risk Reduction Initiative: a call to action to residual vascular risk in dyslipidaemic patients
Jean-Charles Fruchart et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
Xiaomei Qin et al.
HEPATOLOGY (2008)
Updating the effects of fatty acids on skeletal muscle
Leonardo R. Silveira et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Identification and characterization of a selective peroxisome proliferator-activated receptor β/δ (NR1C2) antagonist
Barry G. Shearer et al.
MOLECULAR ENDOCRINOLOGY (2008)
Ligand Activation of Peroxisome Proliferator-Activated Receptor-β/δ Inhibits Cell Proliferation in Human HaCaT Keratinocytes
Michael G. Borland et al.
MOLECULAR PHARMACOLOGY (2008)
Ligand-Mediated Regulation of Peroxisome Proliferator-Activated Receptor (PPAR) β/δ: A Comparative Analysis of PPAR-Selective Agonists and All-trans Retinoic Acid
Markus Rieck et al.
MOLECULAR PHARMACOLOGY (2008)
Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men
Ulf Riserus et al.
DIABETES (2008)
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways
M. T. Audrey Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Role of AMP kinase and PPARδ in the regulation of lipid and glucose metabolism in human skeletal muscle
David Kitz Kraemer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Adipose tissue distribution and quantification of PPARβ/δ and PPARγ1-3 mRNAs:: Discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients
Josiane Woutheres Bortolotto et al.
OBESITY SURGERY (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
The PPARδ agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition
T. Kino et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance
David Sebastian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Triglyceride:: High-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist
Dennis L. Sprecher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Time-dependent effects of fatty acids on skeletal muscle metabolism
Sandro M. Hirabara et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
TLR4 links innate immunity and fatty acid-induced insulin resistance
Hang Shi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes
Michael Schuler et al.
CELL METABOLISM (2006)
Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes
Soonkyu Chung et al.
ENDOCRINOLOGY (2006)
Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytes
Hua-Jun He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Metabolic syndrome: the danger signal in atherosclerosis
Patrick Mathieu et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway
Brian N. Finck et al.
CELL METABOLISM (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The role of AMP-activated protein kinase in mitochondrial biogenesis
Richard M. Reznick et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes - The treating to new targets (TNT) study
James Shepherd et al.
DIABETES CARE (2006)
Resident stem cells are not required for exercise-induced fiber-type switching and angiogenesis but are necessary for activity-dependent muscle growth
P Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
PPARδ:: a dagger in the heart of the metabolic syndrome
GD Barish et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
JN Feige et al.
PROGRESS IN LIPID RESEARCH (2006)
PPARδ regulates glucose metabolism and insulin sensitivity
CH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Peroxisome proliferator-activated receptors and inflammation
Leonardo A. Moraes et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Peroxisome proliferator-activated receptor-α and liver cancer:: where do we stand?
JM Peters et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
G Pascual et al.
NATURE (2005)
Interleukin-6 depletion selectively improves hepatic insulin action in obesity
PJ Klover et al.
ENDOCRINOLOGY (2005)
Inflammation, stress, and diabetes
KE Wellen et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel
J Shepherd et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes
A Planavila et al.
CARDIOVASCULAR RESEARCH (2005)
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
P Gual et al.
BIOCHIMIE (2005)
Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis
FS Harman et al.
NATURE MEDICINE (2004)
Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling
H Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PPARδ status and Apc-mediated tumourigenesis in the mouse intestine
KR Reed et al.
ONCOGENE (2004)
Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy
LH Cheng et al.
NATURE MEDICINE (2004)
Peroxisome proliferator-activated receptor β/δ regulates very low density lipoprotein production and catabolism in mice on a Western diet
TE Akiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Acquiring signalling specificity from the cytokine receptor gp130
M Ernst et al.
TRENDS IN GENETICS (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
T Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone
C Lagathu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor β/δ
N Shaw et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets
EP Haber et al.
FEBS LETTERS (2003)
Diabetic dyslipidaemia: from basic research to clinical practice
MR Taskinen
DIABETOLOGIA (2003)
Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor α activators
N Vu-Dac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ) -: Synthesis and biological activity
ML Sznaidman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
PPARγ is a very low-density lipoprotein sensor in macrophages
A Chawla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cellular mechanism of insulin resistance: potential links with inflammation
G Perseghin et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophy
S Gupta et al.
JOURNAL OF CELL BIOLOGY (2002)
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
LY Rui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Emerging roles of PPARs in inflammation and immunity
RA Daynes et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER
T Yang et al.
CELL (2002)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion
B Vozarova et al.
OBESITY RESEARCH (2001)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies
P Desreumaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells
BH Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase
M Emanuelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators
P Delerive et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G Chinetti et al.
INFLAMMATION RESEARCH (2000)
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity
SI Itani et al.
DIABETES (2000)
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ)
JM Peters et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene
M Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
SOCS-3 is an insulin-induced negative regulator of insulin signaling
B Emanuelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The role of STATs in transcriptional control and their impact on cellular function
J Bromberg et al.
ONCOGENE (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
Regulation of lipid and lipoprotein metabolism by PPAR activators
P Gervois et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2000)
分享论文
